Seoul, South Korea

Insu P Lee

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Insu P Lee. Retrieved from https://idiyas.com/inventor/insu-p-lee-hubv3hpz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 29(Granted Patents)


Company Filing History:

goldMedal1 out of 834,601 
Other
 patents

Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Insu P Lee in Treating Hyperplasia

Introduction

Insu P Lee is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of medical treatments, particularly in addressing hyperplasia caused by the papilloma virus. His innovative approach focuses on utilizing tea catechins, which are known for their safety and ease of administration.

Latest Patents

Insu P Lee holds a patent for a method of treating hyperplasia. This method involves the concomitant topical and oral administration of at least one tea catechin. The use of tea catechins is advantageous as they do not involve the risk of side effects and can be easily administered by patients themselves. This patent highlights the potential for a safer and more accessible treatment option for individuals affected by hyperplasia.

Career Highlights

Throughout his career, Insu P Lee has demonstrated a commitment to advancing medical treatments. His work has led to the development of innovative solutions that prioritize patient safety and ease of use. With a focus on research and development, he continues to explore new avenues for improving health outcomes.

Collaborations

Insu P Lee has collaborated with notable colleagues in his field, including Shu Jun Cheng and De Chang Wang. These partnerships have contributed to the advancement of his research and the successful development of his patented methods.

Conclusion

Insu P Lee's contributions to the treatment of hyperplasia through the use of tea catechins represent a significant advancement in medical innovation. His work not only emphasizes patient safety but also showcases the potential for effective self-administration of treatments. The impact of his inventions is likely to resonate within the medical community for years to come.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…